Tilray Inc (NASDAQ:TLRY - Get Free Report) shot up 2% on Thursday . The company traded as high as $0.47 and last traded at $0.45. 13,005,580 shares were traded during mid-day trading, a decline of 56% from the average session volume of 29,294,615 shares. The stock had previously closed at $0.44.
Analyst Ratings Changes
Several brokerages recently weighed in on TLRY. Piper Sandler dropped their target price on Tilray from $2.00 to $1.00 and set a "neutral" rating for the company in a report on Wednesday, April 9th. Canaccord Genuity Group increased their price objective on Tilray from $2.00 to $3.00 and gave the company a "buy" rating in a research note on Monday, January 13th. Finally, Roth Capital reaffirmed a "neutral" rating on shares of Tilray in a research note on Monday, April 14th.
Read Our Latest Stock Report on TLRY
Tilray Stock Down 2.1 %
The company has a market capitalization of $480.00 million, a P/E ratio of -1.59 and a beta of 1.88. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58. The company has a 50 day moving average of $0.62 and a 200-day moving average of $1.08.
Tilray (NASDAQ:TLRY - Get Free Report) last released its quarterly earnings data on Tuesday, April 8th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.06). The business had revenue of $185.78 million during the quarter, compared to analysts' expectations of $213.38 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. As a group, equities analysts anticipate that Tilray Inc will post -0.2 EPS for the current year.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the stock. Lido Advisors LLC bought a new stake in shares of Tilray during the 4th quarter valued at about $28,000. Verdence Capital Advisors LLC bought a new stake in Tilray during the 4th quarter valued at approximately $29,000. Dudley Capital Management LLC purchased a new position in shares of Tilray during the 4th quarter worth approximately $29,000. Ameritas Advisory Services LLC bought a new position in shares of Tilray in the 4th quarter worth approximately $32,000. Finally, Newman Dignan & Sheerar Inc. lifted its stake in shares of Tilray by 61.9% in the 4th quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock valued at $35,000 after purchasing an additional 10,000 shares during the period. 9.35% of the stock is currently owned by institutional investors.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Recommended Stories
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
